Jeryl Hilleman

Jeryl Hilleman

DirectoratNovoCure· In proxies 2023–2025

Jeryl Hilleman sits on 8 public boards.

Boards1

  • NovoCureDirector · 7 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. NovoCurePublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -79%
  2. Director of HilleVax since 2020 (HilleVax became public in 2022), Inc. since July 2024, Inc. since 2019. Formerly a director of Talis Biomedical from 2021 to 2022Public company
    • Director? – PresentNo stock prices for these years
  3. Director of HilleVax since 2021 (HilleVax became public in 2022), Inc. since 2018, Inc. since 2019. Formerly a director of Talis Biomedical from 2021 to 2022Public company
    • Director? – PresentNo stock prices for these years
  4. Director of Omada Health, Inc. since 2018 and of SI-Bone, Inc. since 2019. Formerly a director of HilleVax from 2020 to September 2025, Cutera, Inc. from July to November 2024, Minerva Neurosciences, Inc. from 2018 to 2024 and of Talis Biomedical from 2021 to 2022Public company
    • Director? – PresentNo stock prices for these years
  5. Minerva Neurosciences, Inc. from 2018 to 2024, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Xenoport, Inc.Public company · 21 yr
    • Director2005 – Present · 21 yrNo stock prices for these years
  7. Cutera, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. Minerva Neurosciences, Inc.Public company · 6 yr
    • Director2018 – 2024 · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?